How to use Alluzience - CPD Accredited

This course is product knowledge only, available to any health professional (doctor, dentist, nurse, etc. ) legally entitled to offer aesthetic injectable treatments in their country/state. Alluzience®, the first ready-to-use BoNT-A neuromodulator has recently been approved for use in Europe, as of January 2025.

It is the first ever already prepared botulinum toxin solution licensed for aesthetic treatment of the glabella. The manufacturer claims that the effects of this new type of toxin last longer than its competitors and has a quicker onset of action, which makes it a promising new product in the field of Medical Aesthetics. This CPD fully accredited course is a step by step guide on how to prepare Alluzience® for injection and, most important, how to understand the conversion to Speywood units needed for a safe and competent treatment.

We compare Alluzience® with the other available brands such as Botox® , Bocouture® , Azzalure® , etc. We also provide you tips to avoid common handling mistakes resulting in waste of product, so you can maximise its use. The author has absolutely no commercial interests with any of the products or brands used in the course.

The training and advice given is from a professional user's point of view, and based on more than 20 years of clinical experience in Medical Aesthetics. We provide you unbiased information about the botulinum toxin commercial preparations, including pharmacology, indications, contra-indications, side-effects and possible complications. At the end of the course, you will be able to test your knowledge with a MCQ quiz.